{
    "title": "106_hr5614",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Seniors' Health Care Restoration Act \nof 2000''.\n\nSEC. 2. INCREASED PAYMENT FOR AREAS WITH TWO OR FEWER MEDICARE+CHOICE \n              CONTRACTS.\n\n    Section 1853 of the Social Security Act (42 U.S.C. 1395w-23) is \namended--\n            (1) in subsection (a)(1)(A), by striking ``and (i)'' and \n        inserting ``(i), and (j)''; and\n            (2) by adding at the end the following new subsection:\n    ``(j) Increased Payment for Areas With 2 or Fewer Medicare+Choice \nContracts.--For months during 2002 and 2003, in the case of a \nMedicare+Choice payment area in which there is no more than two \ncontracts entered into under this part as of July 1 before the \nbeginning of the year involved, the amount of the monthly payment \notherwise made under this section (taking into account, if applicable, \nsubsection (i)) shall be increased by \\1/2\\ percentage point of the \ntotal monthly payment otherwise computed for such payment area.''.\n\nSEC. 3. INCREASE IN MINIMUM PERCENTAGE UPDATE.\n\n    Section 1853(c)(1)(C)(ii) of the Social Security Act (42 U.S.C. \n1395w-23(c)(1)(C)(ii)) is amended by inserting ``(or 104 percent in the \ncase of 2001, 2002, and 2003)'' after ``102 percent''.\n\nSEC. 4. TRANSITION TO REVISED MEDICARE+CHOICE PAYMENT RATES.\n\n    (a) Announcement of Revised Medicare+Choice Payment Rates.--Within \n2 weeks after the date of the enactment of this Act, the Secretary of \nHealth and Human Services shall determine, and shall announce (in a \nmanner intended to provide notice to interested parties) \nMedicare+Choice capitation rates under section 1853 of the Social \nSecurity Act (42 U.S.C. 1395w-23) for 2001, revised in accordance with \nthe provisions of this Act.\n    (b) Reentry Into Program Permitted for Medicare+Choice Programs in \n2000.--A Medicare+Choice organization that provided notice to the \nSecretary of Health and Human Services as of July 3, 2000, that it was \nterminating its contract under part C of title XVIII of the Social \nSecurity Act or was reducing the service area of a Medicare+Choice plan \noffered under such part shall be permitted to continue participation \nunder such part, or to maintain the service area of such plan, for 2001 \nif it provides the Secretary with the information described in section \n1854(a)(1) of the Social Security Act (42 U.S.C. 1395w-24(a)(1)) within \n4 weeks after the date of the enactment of this Act.\n    (c) Revised Submission of Proposed Premiums and Related \nInformation.--If--\n            (1) a Medicare+Choice organization provided notice to the \n        Secretary of Health and Human Services as of July 3, 2000, that \n        it was renewing its contract under part C of title XVIII of the \n        Social Security Act for all or part of the service area or \n        areas served under its current contract, and\n            (2) any part of the service area or areas addressed in such \n        notice includes a county for which the Medicare+Choice \n        capitation rate under section 1853(c) of such Act (42 U.S.C. \n        1395w-23(c)) for 2001, as determined under subsection (a), is \n        higher than the rate previously determined for such year,\nsuch organization shall revise its submission of the information \ndescribed in section 1854(a)(1) of the Social Security Act (42 U.S.C. \n1395w-24(a)(1)), and shall submit such revised information to the \nSecretary, within 4 weeks after the date of the enactment of this Act.\n\nSEC. 5. PROVISION OF EMERGENCY OUTPATIENT PRESCRIPTION DRUG COVERAGE \n              FOR MEDICARE BENEFICIARIES LOSING DRUG COVERAGE UNDER \n              MEDICARE+CHOICE PLANS.\n\n    (a) Temporary Coverage of Outpatient Prescription Drugs for \nMedicare Beneficiaries Losing Prescription Drug Coverage Under \nMedicare+Choice Plans.--\n            (1) In general.--The Secretary of Health and Human Services \n        shall provide for coverage of outpatient prescription drugs to \n        eligible medicare beneficiaries under this section. The \n        Secretary shall provide for such coverage by entering into \n        agreements with eligible organizations to furnish such \n        coverage.\n            (2) Term of emergency coverage.--The Secretary shall \n        provide coverage of outpatient prescription drugs to an \n        eligible medicare beneficiary under this section for the 24-\n        month period beginning on the date the eligible medicare \n        beneficiary loses coverage of outpatient prescription drugs \n        under the Medicare+Choice plan in which the beneficiary is \n        enrolled.\n            (3) Cost-sharing.--With respect to coverage of outpatient \n        prescription drugs furnished under this section, benefits under \n        this section shall not begin until the eligible medicare \n        beneficiary has met a $50 deductible.\n            (4) Payment.--The Secretary shall provide for payment for \n        such coverage under this section from the Emergency Reserve \n        Outpatient Prescription Drug Account established under \n        subsection (b).\n    (b) Account for Emergency Outpatient Prescription Drug Benefit in \nSMI Trust Fund.--\n            (1) Establishment.--There is hereby established in the \n        Federal Supplementary Medical Insurance Trust Fund under \n        section 1841 of the Social Security Act (42 U.S.C. 1395t) an \n        expenditure account to be known as the ``Emergency Reserve \n        Outpatient Prescription Drug Account''.\n            (2) Crediting of funds.--The Managing Trustee shall credit \n        to the Emergency Reserve Outpatient Prescription Drug Account \n        such amounts as may be deposited in the Federal Supplementary \n        Medical Insurance Trust Fund as follows:\n                    (A) Amounts appropriated to the account.\n                    (B) Amounts equal to the annual outstanding balance \n                of the Health Care Fraud and Abuse Control Account \n                under section 1817(k) of the Social Security Act (42 \n                U.S.C. 1395i(k)) at the end of each fiscal year that \n                the Secretary determines may be made available to the \n                Emergency Reserve Outpatient Prescription Drug Account.\n            (3) Use of funds.--Funds credited to the Outpatient \n        Prescription Drug Account may only be used to pay for \n        outpatient prescription drugs (and associated administrative \n        costs) furnished under this section.\n            (4) Conforming amendment.--Section 1817(k)(3)(C) of such \n        Act (42 U.S.C. 1395i(k)(3)(C)) is amended--\n                    (A) by striking ``and'' at the end of clause (iv);\n                    (B) by striking the period at the end of clause (v) \n                and inserting ``; and''; and\n                    (C) by adding at the end the following new clause:\n                            ``(vi) providing temporary emergency \n                        coverage of outpatient prescription drugs for \n                        eligible beneficiaries under section 5 of the \n                        Seniors' Health Care Restoration Act of \n                        2000.''.\n    (c) Definitions.--In this section:\n            (1) Eligible medicare beneficiary.--The term ``eligible \n        medicare beneficiary'' means an individual--\n                    (A) who is enrolled in a Medicare+Choice plan under \n                part C of title XVIII of the Social Security Act; and\n                    (B)(i) whose enrollment in such plan is terminated \n                or may not be renewed or whose service area has been \n                reduced for the next contract year because the plan has \n                been terminated or will not be offered in such contract \n                year; or\n                    (ii) whose coverage of outpatient prescription \n                drugs under such plan has been terminated, \n                significantly reduced, or no longer provides for the \n                coverage of a particular outpatient prescription drug \n                required.\n            (2) Covered outpatient drug.--\n                    (A) In general.--Except as provided in subparagraph \n                (B), the term ``covered outpatient drug'' means any of \n                the following products:\n                            (i) A drug which may be dispensed only upon \n                        prescription, and--\n                                    (I) which is approved for safety \n                                and effectiveness as a prescription \n                                drug under section 505 of the Federal \n                                Food, Drug, and Cosmetic Act;\n                                    (II)(aa) which was commercially \n                                used or sold in the United States \n                                before the date of enactment of the \n                                Drug Amendments of 1962 or which is \n                                identical, similar, or related (within \n                                the meaning of section 310.6(b)(1) of \n                                title 21 of the Code of Federal \n                                Regulations) to such a drug, and (bb)  \nwhich has not been the subject of a final determination by the \nSecretary that it is a ``new drug'' (within the meaning of section \n201(p) of the Federal Food, Drug, and Cosmetic Act) or an action \nbrought by the Secretary under section 301, 302(a), or 304(a) of such \nAct to enforce section 502(f) or 505(a) of such Act; or\n                                    (III)(aa) which is described in \n                                section 107(c)(3) of the Drug \n                                Amendments of 1962 and for which the \n                                Secretary has determined there is a \n                                compelling justification for its \n                                medical need, or is identical, similar, \n                                or related (within the meaning of \n                                section 310.6(b)(1) of title 21 of the \n                                Code of Federal Regulations) to such a \n                                drug, and (bb) for which the Secretary \n                                has not issued a notice of an \n                                opportunity for a hearing under section \n                                505(e) of the Federal Food, Drug, and \n                                Cosmetic Act on a proposed order of the \n                                Secretary to withdraw approval of an \n                                application for such drug under such \n                                section because the Secretary has \n                                determined that the drug is less than \n                                effective for all conditions of use \n                                prescribed, recommended, or suggested \n                                in its labeling.\n                            (ii) A biological product which--\n                                    (I) may only be dispensed upon \n                                prescription;\n                                    (II) is licensed under section 351 \n                                of the Public Health Service Act; and\n                                    (III) is produced at an \n                                establishment licensed under such \n                                section to produce such product.\n                            (iii) Insulin approved under appropriate \n                        Federal law.\n                            (iv) A prescribed drug or biological \n                        product that would meet the requirements of \n                        clause (i) or (ii) but that is available over-\n                        the-counter in addition to being available upon \n                        prescription.\n                    (B) Exclusion.--The term ``covered outpatient \n                drug'' does not include any product--\n                            (i) except as provided in subparagraph \n                        (A)(iv), which may be distributed to \n                        individuals without a prescription;\n                            (ii) when furnished as part of, or as \n                        incident to, a diagnostic service or any other \n                        item or service for which payment may be made \n                        under title XVIII of the Social Security Act; \n                        or\n                            (iii) that is a therapeutically equivalent \n                        replacement for a product described in clause \n                        (i) or (ii), as determined by the Secretary.\n            (3) Eligible organization.--The term ``eligible \n        organization'' means any organization that the Secretary \n        determines to be appropriate, including--\n                    (A) pharmaceutical benefit management companies;\n                    (B) wholesale and retail pharmacist delivery \n                systems;\n                    (C) insurers;\n                    (D) other organizations; or\n                    (E) any combination of the entities described in \n                subparagraphs (A) through (D).\n            (4) Secretary.--The term ``Secretary'' means the Secretary \n        of Health and Human Services."
}